FDA Approves METFORMIN HYDROCHLORIDE — Oceanside Pharmaceuticals

Oceanside Pharmaceuticals announced the FDA approval of oral Metformin Hydrochloride (NDA021748), a market expansion that offers a potential cost-effective alternative for Type 2 diabetes management. The entry of a generic alternative is expected to intensify competitive pricing pressure within the metformin class.